Literature DB >> 20683069

Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients.

K M Chow1, Y L Poon, M P Lam, K L Poon, C C Szeto, Philip K T Li.   

Abstract

OBJECTIVE: To investigate the effect of antibiotic lock solutions for preventing catheter-related bacteraemia in patients receiving haemodialysis.
DESIGN: Retrospective study.
SETTING: University teaching hospital, Hong Kong. PATIENTS: Consecutive patients from March 2006 to April 2007 who had central venous catheter insertion for haemodialysis in our centre were included in this historically controlled study. In all, 75 patients had catheters with heparin solution alone and 74 had catheters with a gentamicin antibiotic lock. The majority of catheters were non-tunnelled (95%). Cumulative catheter survival free of catheter-related bacteraemia in the two groups was compared.
RESULTS: Baseline characteristics in the two groups were similar apart from a slightly lower serum albumin level in those with gentamicin locks. There were 18 and five catheter-related bacteraemia episodes before and after recourse to gentamicin antibiotic locks, respectively. Staphylococcus aureus contributed to over half (65%) of the total bacteraemia episodes. Use of gentamicin antibiotic locks significantly reduced catheter-related bacteraemia episodes per 1000 catheter days from 4.6 to 1.5 (P=0.002). Kaplan-Meier survival analysis using the log rank test showed significantly better bloodstream infection-free survival associated with using gentamicin antibiotic locks (P=0.032). A similar survival advantage was associated with gentamicin antibiotic locks when the analysis was restricted to non-tunnelled catheters. There was no significant association of catheter-related bacteraemia with patient age, obesity, gender, baseline serum albumin level, or diabetes mellitus. No serious adverse events were attributable to the use of gentamicin antibiotic locks.
CONCLUSION: Use of gentamicin lock solutions effectively reduced catheter-related bacteraemia in haemodialysis patients, including those with non-tunnelled catheters.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683069

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  3 in total

1.  Prevention of central line-associated bloodstream infections: a journey toward eliminating preventable harm.

Authors:  Kristina R Weeks; Christine A Goeschel; Sara E Cosgrove; Mark Romig; Sean M Berenholtz
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

Review 2.  Infectious complications in dialysis--epidemiology and outcomes.

Authors:  Philip Kam-Tao Li; Kai Ming Chow
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

3.  Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime.

Authors:  Mojgan Mortazavi; Samira Alsaeidi; Roohollah Sobhani; Fereshte Salimi; Abdolamir Atapour; Nima Sharif; Mojtaba Akbari; Bahram Pakzad; Amir Hosein Davarpanah Jazi
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.